CDC25B and acute myeloid leukemia: As previously reported, siRNA-mediated depletion of FOXM1 expression, or TMPP treatment, induced G2/M cell cycle arrest and inhibited AML cell proliferation through a decrease in protein expression of mitotic regulators such as Cdc25B in AML cells [1], [2].